All In MedTech

FDA Clearance Tracker

Clearance trends: Neuromodulation

How many devices FDA lets onto the market, in which specialties, and how long its reviews take. Counts are FDA decisions, not devices sold or used.

Last checked: Nov 20, 2026Latest source record: Nov 8, 2026 (newest decision)Source: openFDAMethods & limitations

Decisions per month: Neuromodulation

The last 36 months, by pathway. PMA counts are original approvals and panel-track supplements. The newest month is incomplete.

  • 510(k)
  • De Novo
  • PMA
View as table
Month510(k)De NovoPMA
Dec 23510
Jan 24300
Feb 24402
Mar 24201
Apr 24100
May 24300
Jun 24400
Jul 24300
Aug 24601
Sep 24000
Oct 24200
Nov 24400
Dec 24211
Jan 25210
Feb 25301
Mar 25400
Apr 25300
May 25300
Jun 25501
Jul 25501
Aug 25701
Sep 25301
Oct 25310
Nov 25201
Dec 25202
Jan 26210
Feb 26500
Mar 26401
Apr 26600
May 26710
Jun 26200
Jul 26100
Aug 26400
Sep 26200
Oct 26000
Nov 26000

See the Neuromodulation decisions

Decisions per year, by specialty

The 6 specialties with the most decisions since 2015. All specialties are in the table below. 2026 is a partial year.

  • Orthopedic Surgery
  • Radiology & Imaging
  • Cardiology
  • General & Plastic Surgery
  • Laboratory Medicine & Pathology
  • Hospital Medicine & Nursing
View as table
YearOrthopedic SurgeryRadiology & ImagingCardiologyGeneral & Plastic SurgeryLaboratory Medicine & PathologyHospital Medicine & Nursing
2015593348411290272182
2016477380392334265215
2017581396405323317237
2018523414397277296213
2019539354373273267199
2020546421370287196193
2021431409330517143368
2022429412354461198401
2023510455405396302271
2024453417361390263201
2025412483372386281194
2026 so far395416403327235131

Every specialty, year by year

510(k) clearances, De Novo grants, original PMA approvals and panel-track PMA supplements, grouped by FDA review panel.

Specialty201520162017201820192020202120222023202420252026*Total
Orthopedic Surgery5934775815235395464314295104534123955,889
Radiology & Imaging3483803964143544214094124554174834164,905
Cardiology4113924053973733703303544053613724034,573
General & Plastic Surgery2903343232772732875174613963903863274,261
Laboratory Medicine & Pathology2722653172962671961431983022632812353,035
Hospital Medicine & Nursing1822152372131991933684012712011941312,805
Dentistry & Oral Surgery2422322272102232592142502482612301952,791
GI, Urology & Nephrology1871792012352132091642042352232652192,534
Neurology & Neurosurgery1331452021741651611751762051992411892,165
Anesthesiology & Respiratory8395871007688706410297100831,045
Obstetrics & Gynecology9575899078797477768494951,006
Physical Medicine & Rehabilitation776958576459828181103113123967
Ophthalmology588073735455375651614340681
Otolaryngology (ENT)524235394331395253384550519

* 2026 is a partial year.

How long FDA takes to decide

Calendar days from the date FDA received the submission to the date it decided. This includes time the clock was stopped while FDA waited for the applicant, so it is longer than FDA's own review-day figures.

PathwayMedian daysMiddle halfBased on
510(k)13382 to 233The 1,000 most recent clearances, decided Jul 24, 2026 to Nov 8, 2026
De Novo326244 to 362The 150 most recent grants, decided 2023 to 2026
PMA (original)342226 to 529The 200 most recent approvals, decided 2020 to 2026

"Middle half" is the range from the 25th to the 75th percentile: half of the decisions in the sample took between those two numbers of days.

510(k) time to decision, by specialty

Median calendar days, from the same sample of recent 510(k) clearances. Specialties with fewer than 15 clearances in the sample are left out.

9 more in this ranking with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.